HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 25
Healthy Volunteers: f
View:

• Patient has received a liver transplant \>1 year ago

• Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.

• Patient has an unmet social risk (e.g., food insecurity) or MLVI \>/= 2.0.

• Patient will be transferred to adult transplant team in \<6 months.

• Patient can read and write English or Spanish

• Patient is between 18-25 years old and can provide informed consent.

• Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom.

Locations
United States
California
University of California San Francisco
RECRUITING
San Francisco
Georgia
Children's Healthcare of Atlanta
NOT_YET_RECRUITING
Atlanta
Contact Information
Primary
Sharad Wadhwani, MD, MPH
sharad.wadhwani@ucsf.edu
510-428-3058
Time Frame
Start Date: 2024-03-03
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 20
Treatments
Experimental: Intervention
This is a single arm pilot intervention.
Related Therapeutic Areas
Sponsors
Collaborators: American Society of Transplantation
Leads: University of California, San Francisco

This content was sourced from clinicaltrials.gov